Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.82 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | TOP2A | P11388 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.69 |
| ▸ | PIK3CG | P48736 | 7/20 | 0.64 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.64 |
| ▸ | PIK3R1 | P27986 | 5/20 | 0.64 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350842 | 0.90 | KDM4E (1.00) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL10809240 | 0.90 | KDM4E (1.00) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL21160033 | 0.87 | KDM4E (0.77) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL825059 | 0.86 | KDM4E (0.92) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL10959265 | 0.86 | KDM4E (0.78) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL10807306 | 0.86 | KDM4E (0.81) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL13040619 | 0.86 | KDM4E (0.71) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL29576608 | 0.86 | ALDH1A1 (0.81) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL2780752 | 0.86 | ALDH1A1 (0.81) | KDM4EALDH1A1LMNAHSD17B10HPGD | |
| SCHEMBL10924388 | 0.85 | KDM4E (0.80) | KDM4EALDH1A1LMNAHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7777033-B2 | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof | MICRO SCIENCE TECH CO., LTD. (KR) | 2010-08-17 | — | — | US | claimed |
| US-20080188655-A1 | Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof | MICRO SCIENCE TECH CO., LTD. (KR) | 2008-08-07 | — | — | US | claimed |
| US-20100278920-A1 | Polyacrylate Nanoparticle Drug Delivery | UNIVERSITY OF SOUTH FLORIDA (US) | 2010-11-04 | — | — | US | disclosed |
| US-20100278920-A1 | Polyacrylate Nanoparticle Drug Delivery | UNIVERSITY OF SOUTH FLORIDA (US) | 2010-11-04 | — | — | US | disclosed |
| US-7777033-B2 | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof | MICRO SCIENCE TECH CO., LTD. (KR) | 2010-08-17 | — | — | US | disclosed |
| US-20080188655-A1 | Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof | MICRO SCIENCE TECH CO., LTD. (KR) | 2008-08-07 | — | — | US | disclosed |
| US-7361719-B2 | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof | MICRO SCIENCE TECH CO., LTD. (KR) | 2008-04-22 | — | — | US | disclosed |
| US-20050176905-A1 | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof | MICRO SCIENCE TECH CO., LTD. (KR) | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188655-A1 | Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof | PCNA, HSF1, TERB1 | KDM4E 1725/4885ALDH1A1 2231/4885LMNA 2084/4885 |
| US-20100278920-A1 | Polyacrylate Nanoparticle Drug Delivery | ABCC1, PARG, SLC11A2 | KDM4E 758/4885ALDH1A1 1936/4885LMNA 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.